Evidence map›Paper›PMID 30397070›Full record

ArticleAntimicrobial agents and chemotherapy2019

Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.

Angela Kavanagh, Soumya Ramu, Yujing Gong, Matthew A Cooper, Mark A T Blaskovich

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Characterisation ofJAC-antimicrobial resistance · 2025
    Article
  5. HybridPharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Vancomycin-Teixobactin Conjugates.Journal of the American Chemical Society · 2025
    Article
  7. Article
  8. Review
  9. Investigation of Isobactin Analogues of Teixobactin.ACS medicinal chemistry letters · 2024
    Article
  10. Article
  11. Article
  12. Antimicrobial agents and chemotherapy · 2023
    Article
  13. Article
  14. ROS-Induced DNA-Damage and Autophagy in Oral Squamous Cell Carcinoma byInternational journal of molecular sciences · 2022
    Article
  15. Isobactins:Chemical science · 2022
    Article
  16. Article
  17. Evaluation ofAntioxidants (Basel, Switzerland) · 2022
    Article
  18. Article
  19. Review
  20. Diagnostics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Angela Kavanagh *Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.
Soumya Ramu *Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.
Yujing GongInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.
Matthew A CooperInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia m.cooper@uq.edu.au m.blaskovich@uq.edu.au.
Mark A T BlaskovichInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia m.cooper@uq.edu.au m.blaskovich@uq.edu.au.ORCID 0000-0001-9447-2292
The University of Queensland · AU

Funding

Discovery of Polymyxin-based Antibacterial Agents Active Against Multi-Drug ResisR33AI098731 · NIAID · UNIVERSITY OF QUEENSLAND · PI COOPER, MATTHEW A, LASH, LAWRENCE H. · 2014 to 2016
$945k
Discovery of Polymyxin-based Antibacterial Agents Active Against Multi-Drug ResisR21AI098731 · NIAID · UNIVERSITY OF QUEENSLAND · PI COOPER, MATTHEW A, LASH, LAWRENCE H. · 2012 to 2013
$290k
NIAID NIH HHS R21 AI098731NIAID NIH HHS R33 AI098731Wellcome TrustWellcome Trust 094977/Z/10/Z
6 · The paper itself

Abstract

The determination of antibiotic potency against bacterial strains by assessment of their minimum inhibitory concentration normally uses a standardized broth microdilution assay procedure developed more than 50 years ago. However, certain antibiotics require modified assay conditions in order to observe optimal activity. For example, daptomycin requires medium supplemented with Ca

Indexed as

AminoglycosidesAnti-Bacterial AgentsCalciumCiprofloxacinColistinCulture MediaDepsipeptidesEscherichia coliFactor Analysis, StatisticalLipoglycopeptidesMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsOxacillinPenicillin GPlasticsPolymyxin BAminoglycosidesAnti-Bacterial AgentsCalciumCiprofloxacinColistinCulture MediadalbavancinDepsipeptidesLipoglycopeptidesoritavancinOxacillinPenicillin GPlasticsPolymyxin BPolysorbatesramoplaninRifampinTeicoplanintelavancinTrimethoprimVancomycinadditive effectsbroth microdilution assayMICmicrotiter plate effects

Identifiers

PMID30397070
PMCPMC6325200
OpenAlexW2905988983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.